标题/作者	年份
Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382	2021
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro J Liu, R Cao, M Xu, X Wang, H Zhang, H Hu, Y Li, Z Hu, W Zhong, ... Cell discovery 6 (1), 1-4	2020
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology E Schrezenmeier, T Dörner Nature Reviews Rheumatology 16 (3), 155-166	2020
COVID-19: Transmission, prevention, and potential therapeutic opportunities M Lotfi, MR Hamblin, N Rezaei Clinica chimica acta 508, 254-266	2020
Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973	2019
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection J Fantini, C Di Scala, H Chahinian, N Yahi International journal of antimicrobial agents 55 (5), 105960	2020
An update on current therapeutic drugs treating COVID-19 R Wu, L Wang, HCD Kuo, A Shannar, R Peter, PJ Chou, S Li, R Hudlikar, ... Current pharmacology reports 6 (3), 56-70	2020
Amino acids: biochemistry and nutrition G Wu CRC Press	2021
Potential therapeutic agents against COVID-19: What we know so far CC Lu, MY Chen, YL Chang Journal of the Chinese Medical Association	2020
Rapid repurposing of drugs for COVID-19 RK Guy, RS DiPaola, F Romanelli, RE Dutch Science 368 (6493), 829-830	2020
COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies D Atri, HK Siddiqi, JP Lang, V Nauffal, DA Morrow, EA Bohula Basic to Translational Science 5 (5), 518-536	2020
Overcoming cancer therapeutic bottleneck by drug repurposing Z Zhang, L Zhou, N Xie, EC Nice, T Zhang, Y Cui, C Huang Signal transduction and targeted therapy 5 (1), 1-25	2020
COVID-19 outbreak in Malaysia A Elengoe Osong public health and research perspectives 11 (3), 93	2020
Autophagy in cancer: moving from understanding mechanism to improving therapy responses in patients JM Mulcahy Levy, A Thorburn Cell Death & Differentiation 27 (3), 843-857	2020
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—an observational study A Ip, DA Berry, E Hansen, AH Goy, AL Pecora, BA Sinclaire, U Bednarz, ... PloS one 15 (8), e0237693	2020
COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies AD Deepak, KS Hasan, LMD Joshua, NFD Victor, AM David, AB Erin JACC; Basic to Translational science	2020
Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment S Cicco, G Cicco, V Racanelli, A Vacca Mediators of inflammation 2020	2020
Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic-and endo-lysosomal systems go extracellular S Buratta, B Tancini, K Sagini, F Delo, E Chiaradia, L Urbanelli, C Emiliani International journal of molecular sciences 21 (7), 2576	2020
Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives-A better synergy for future COVID-19 clinical trials MO Shittu, OI Afolami Infez Med 28 (2), 192-197	2020
Is hydroxychloroquine beneficial for COVID-19 patients? X Li, Y Wang, P Agostinis, A Rabson, G Melino, E Carafoli, Y Shi, E Sun Cell death & disease 11 (7), 1-6	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。